Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 20/20 | 0.65 |
| ▸ | SLC2A3 | P11169 | 19/20 | 0.65 |
| ▸ | SLC2A4 | P14672 | 18/20 | 0.65 |
| ▸ | SLC2A2 | P11168 | 9/20 | 0.63 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.52 |
| ▸ | HRH2 | P25021 | 1/20 | 0.52 |
| ▸ | HRH1 | P35367 | 1/20 | 0.52 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18320815 | 0.93 | SLC2A1 (0.70) | SLC2A1SLC2A3SLC2A4SLC2A2ADORA3 | |
| SCHEMBL18320989 | 0.92 | SLC2A1 (0.69) | SLC2A1SLC2A3SLC2A4SLC2A2ADORA3 | |
| SCHEMBL18320820 | 0.91 | SLC2A1 (0.68) | SLC2A1SLC2A3SLC2A4SLC2A2ADORA3 | |
| SCHEMBL18320796 | 0.91 | SLC2A1 (0.68) | SLC2A1SLC2A3SLC2A4SLC2A2PTGER4 | |
| SCHEMBL18320824 | 0.90 | SLC2A1 (0.66) | SLC2A1SLC2A3SLC2A4SLC2A2ADORA3 | |
| SCHEMBL18320799 | 0.90 | SLC2A1 (0.72) | SLC2A1SLC2A3SLC2A4SLC2A2ADORA3 | |
| SCHEMBL18321237 | 0.90 | SLC2A1 (0.67) | SLC2A1SLC2A3SLC2A4SLC2A2PTGER4 | |
| SCHEMBL18321232 | 0.89 | SLC2A1 (0.63) | SLC2A1SLC2A3SLC2A4SLC2A2 | |
| SCHEMBL18320563 | 0.89 | SLC2A1 (0.65) | SLC2A1SLC2A3SLC2A4SLC2A2ADORA3 | |
| SCHEMBL18320545 | 0.89 | SLC2A1 (0.65) | SLC2A1SLC2A3SLC2A4SLC2A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016202898-A1 | GLUCOSE TRANSPORT INHIBITORS | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2016-12-22 | — | — | WO | claimed |